| Literature DB >> 32489241 |
Bryan Ping Ho Chung1, Wendy Kam Ha Chiang2, Herman Lau3, Titanic Fuk On Lau1, Charles Wai Kin Lai2, Claudia Sin Yi Sit1, Ka Yan Chan2, Chau Yee Yeung1, Tak Man Lo1, Elsie Hui4, Jenny Shun Wah Lee5.
Abstract
OBJECTIVE: To compare the effectiveness of mobile video-guided home exercise program and standard paper-based home exercise program.Entities:
Keywords: Physiotherapy; adherence; exercise; functional outcome; home; rehabilitation; self-efficacy; stroke; video
Year: 2020 PMID: 32489241 PMCID: PMC7136530 DOI: 10.1142/S1013702520500079
Source DB: PubMed Journal: Hong Kong Physiother J ISSN: 1013-7025
Type of home exercises in both experimental group and control group.
| Arm control exercise |
|
Shoulder elevation in lying (Active) Shoulder elevation in lying (Active-assisted) Elbow flexion/extension (Active) Elbow flexion/extension (Active-assisted) Shoulder elevation in sitting (Active) Shoulder elevation in sitting (Active Assisted) Weight-bearing to affected arm (Active) Shoulder horizontal abduction/adduction (Active) Hand grasp and release (Active) |
| Leg control exercise |
|
Hip abduction/adduction in lying (Both leg) (Active) Hip abduction/adduction in lying (Affected leg) (Active) Hip abduction/adduction in lying (Both leg) (Active-assisted) Hip and knee flexion/extension in lying (Active) Hip and knee flexion/extension in lying (Active-assisted) Knee extension in sitting (Active) |
| Trunk control exercise |
|
Trunk rotation (Active) Trunk rotation (Active-assisted) Double-leg bridging (Active) Single-leg bridging (Active) Double-leg bridging (Active-assisted) Forward reaching (Active) |
| Mobility |
|
Sit to stand (Active Assisted) Weight-shifting in sideway (Active Assisted) Stepping back and forward (Active Assisted) Semi-squat (Active Assisted) |
Fig. 1.Design and flow of participants through the trial.
Baseline characteristics of participants.
| Characteristic | Total | Exp | Con | Chi-Square | |
|---|---|---|---|---|---|
| Participants Age (years), mean (SD), (Range) | 69.8(14.9), 38–93 | 66.9(14.0), 40–93 | 72.5(15.5), 38–93 | 0.166 | |
| Gender, | 31(55.4) | 14(51.9) | 17(58.6) | 0.611 | |
| Time since stroke (days), mean (SD), (Range) | 39.5(15.3), 11–89 | 41.3(16.5), 23–89 | 37.9(14.2), 11–64 | 0.407 | |
| Type of stroke (%) | 0.838 | ||||
| Infract | 45(80.4) | 22(81.5) | 23(79.3) | ||
| Hemorrhage | 11(19.6) | 5(18.5) | 6(20.7) | ||
| Side of hemiplegia (%) | 0.571 | ||||
| Left | 25(44.6) | 11(40.7) | 14(48.3) | ||
| Right | 31(55.4) | 16(59.3) | 15(51.7) | ||
| Complication (%) | 0.568 | ||||
| Neglect | 5(8.9) | 3(11.1) | 2(6.9) | ||
| Dysphasia | 9(16.1) | 3(11.1) | 6(20.7) | ||
| Nil | 42(75.0) | 21(77.8) | 21(72.4) | ||
| Site of lesion (%) | 0.635 | ||||
| Cortex | 11(19.6) | 6(22.2) | 5(17.2) | ||
| Corona radiata | 7(12.5) | 4(14.8) | 3(10.3) | ||
| Internal capsule | 8(14.3) | 5(18.5) | 3(10.3) | ||
| Putamen | 1(1.8) | 1(3.7) | 0 | ||
| Thalamus | 6(10.7) | 2(7.4) | 4(13.8) | ||
| Other | 23(41.1) | 9(33.3) | 14(48.3) | ||
| Follow-up physiotherapy (%) | 0.151 | ||||
| Ambulatory day hospital | 38(67.9) | 21(77.8) | 17(58.6) | ||
| Domiciliary physiotherapy | 3(5.4) | 2(7.4) | 1(3.5) | ||
| Other | 2(3.6) | 0 | 2(6.9) | ||
| Nil | 13(23.2) | 4(14.8) | 9(31.0) | ||
| Type of carer (%) | 0.572 | ||||
| No | 15(26.8) | 10(37.0) | 5(17.2) | ||
| Spouse | 11(19.6) | 5(18.5) | 6(20.7) | ||
| Maid | 6(10.7) | 1(3.7) | 5(17.2) | ||
| Children | 21(37.5) | 10(37) | 11(37.9) | ||
| Other | 3(5.4) | 1(3.7) | 2(6.9) | ||
| Experience in smart device | 0.598 | ||||
| | 8(14.3) | 3(11.1) | 5(17.2) | ||
| 1–2 years | 8(14.3) | 5(18.5) | 3(10.3) | ||
| | 40(71.4) | 19(70.4) | 21(72.4) | ||
| MFAC | 4.0(1.4) | 4.3(1.0) | 3.8(1.7) | 0.173 | |
| MBI | 58.0(26.3) | 65.1(20.7) | 51.4(29.4) | 0.048* |
Notes: Exp: experimental group; Con: control group; difference between groups by independent -test or Chi-Square test. *.
Exercise adherence and self-efficacy for exercise of experience and control groups.
| Groups | Between-group | Groups | Between-group | Groups | Between-group | ||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | 1-Month | 3-Month | |||||||
| Exp | Con | Exp | Con | Exp | Con | ||||
| Adherence | |||||||||
| Mean (SD) | 74.1 | 64.1 | 0.214 | 73.7 | 58.6 | 0.072 | 75.6 | 55.2 | 0.021* |
| (24.4) | (34.0) | (21.5) | (37.3) | (26.2) | (35.8) | ||||
| SEE | |||||||||
| Mean (SD) | 52.5 | 48.1 | 0.307 | 58.4 | 43.3 | 0.001* | 62.2 | 45.6 | |
| (15.2) | (16.7) | (11.7) | (20.0) | (10.7) | (18.8) | ||||
Notes: Exp: experimental group; Con: control group; difference between groups of Adherence by Chi-Square test; difference between groups of SEE by independent -test.
.
Functional outcomes of experience and control groups.
| Groups | Within-groups | Between-group | Within-groups | Between-group | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 1-month | 3-month | 1-month gain (1-month minus baseline) | 3-month gain (3-month minus baseline) | ||||||||
| Exp | Con | Exp | Con | Exp | Con | Exp | Con | Exp | Con | |||
| MFAC | ||||||||||||
| Mean (SD) | 4.3 | 3.8 | 5.1 | 4.3 | 6.0 | 4.8 | 0.9 | 0.5 | 1.7 | 1.0 | ||
| (1.0) | (4.3) | (1.1) | (1.6) | (1.2) | (1.8) | (0.9) | (0.6) | (1.2) | (1.0) | |||
| | 0.124 | 0.036* | ||||||||||
| MBI | ||||||||||||
| Mean (SD) | 65.1 | 51.4 | 79.0 | 63.2 | 85.4 | 70.8 | 13.9 | 11.9 | 20.9 | 19.4 | ||
| (20.7) | (29.4) | (15.6) | (30.0) | (17.3) | (29.0) | (12.0) | (8.4) | (13.9) | (13.1) | |||
| | 0.474 | 0.808 | ||||||||||
Notes: Exp: experimental group; Con: control group; difference within groups by pair t-test; difference between groups by independent -test.
0.05.